Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company offers Wundecyte, a wound-healing gel. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
http://www.priceseries.com/trade/TENX-Tenax-Therapeutics-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019031420190322.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments